Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Toshio Tanaka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Toshio Kurihara < Toshio Tanaka < Toshiro Takafuta  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000792 (2018) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Interleukin (IL-6) Immunotherapy.
000816 (2018) Atsuhiko Iuchi [Japon] ; Hiroshi Harada [Japon] ; Toshio Tanaka [Japon]IL-6 blockade for myocardial infarction.
000A24 (2017) Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
000E31 (2016) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Immunotherapeutic implications of IL-6 blockade for cytokine storm.
000F96 (2015) Sujin Kang [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]Therapeutic uses of anti-interleukin-6 receptor antibody.
001020 (2015) Atsushi Ogata [Japon] ; Takayoshi Morita ; Yuji Yoshida ; Toshio TanakaSubcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.
001104 (2015) Toshio TanakaIL-6 blockade therapy for inflammatory diseases: current perspectives and future directions.
001119 (2015) Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
001265 (2014) Toshio Tanaka [Japon] ; Tadamitsu KishimotoThe biology and medical implications of interleukin-6.
001310 (2014) Atsushi Ogata [Japon] ; Kazuhide Tanimura ; Toyohiko Sugimoto ; Hiroshi Inoue ; Yukitomo Urata ; Tsukasa Matsubara ; Masakazu Kondo ; Yukitaka Ueki ; Mitsuhiro Iwahashi ; Shigeto Tohma ; Shuji Ohta ; Yukihiko Saeki ; Toshio TanakaPhase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.
001323 (2014) Toshio Tanaka [Japon] ; Yoshihiro Hishitani [Japon] ; Atsushi Ogata [Japon]Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.
001342 (2014) Yuji Yoshida [Japon] ; Toshio Tanaka [Japon]Interleukin 6 and rheumatoid arthritis.
001349 (2014) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]IL-6 in inflammation, immunity, and disease.
001432 (2014) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon]A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
001481 (2013) Yoshikazu Nakaoka ; Kaori Higuchi ; Yoh Arita ; Michio Otsuki ; Kaori Yamamoto ; Takahiro Hashimoto-Kataoka ; Taku Yasui ; Kuniyasu Ikeoka ; Tomohito Ohtani ; Yasushi Sakata ; Yoshihito Shima ; Atsushi Kumanogoh ; Keiko Yamauchi-Takihara ; Toshio Tanaka ; Tadamitsu Kishimoto ; Issei KomuroTocilizumab for the treatment of patients with refractory Takayasu arteritis.
001617 (2013) Toshio Tanaka [Japon]Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?
001675 (2012) Atsushi Ogata [Japon] ; Toshio TanakaTocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.
001680 (2012) Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu KishimotoTherapeutic targeting of the interleukin-6 receptor.
001692 (2012) Toshio Tanaka [Japon] ; Tadamitsu KishimotoTargeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
001714 (2012) Atsushi Ogata [Japon] ; Toru Hirano ; Yoshihiro Hishitani ; Toshio TanakaSafety and efficacy of tocilizumab for the treatment of rheumatoid arthritis.
001726 (2012) Atsushi Ogata [Japon] ; Noriko Umegaki ; Ichiro Katayama ; Atsushi Kumanogoh ; Toshio TanakaPsoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Toshio Tanaka" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Toshio Tanaka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Toshio Tanaka
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021